Intrathecal baclofen in the management of spasticity due to cerebral palsy.
نویسندگان
چکیده
Intrathecal baclofen is a cornerstone in the treatment of spasticity in children. However, further research is required to set criteria for treatment. This paper offers insight into the national act on baclofen and the experience at the Nottingham University Hospital.
منابع مشابه
Intrathecal baclofen withdrawal syndrome- a life-threatening complication of baclofen pump: A case report
BACKGROUND Intrathecal baclofen pump has been used effectively with increasing frequency in patients with severe spasticity, particularly for those patients who are unresponsive to conservative pharmacotherapy or develop intolerable side effects at therapeutic doses of oral baclofen. Drowsiness, nausea, headache, muscle weakness, light-headedness and return of pretreatment spasticity can be cau...
متن کاملImprovements in children with cerebral palsy following intrathecal baclofen: use of the Rehabilitation Institute of Chicago Care and Comfort Caregiver Questionnaire (RIC CareQ).
Implantation of an intrathecal baclofen pump is recommended for children with cerebral palsy as a means to improve care and comfort when other options fail to control severe hypertonia. Making an assessment of a child's spasticity-related limitations in both routine care and activity is a necessary component of selection of intrathecal baclofen candidates. The Rehabilitation Institute of Chicag...
متن کاملFifteen year experience of intrathecal baclofen treatment in Japan.
Intrathecal baclofen administration is a fully established treatment for severe spasticity. However, it is scarcely known that Baclofen, an agonist of GABA-B receptor, has other potential effects on pain, restoration coma, dystonia, tetanus, and hypothalamic storm. Sporadic episodes of dramatic recovery from persistent vegetative state are reported after intrathecal administration of baclofen. ...
متن کاملTreating complex movement disorders in children with cerebral palsy
Cerebral palsy is common, affecting about 2-3 per 1000 children. These children may have a motor disorder characterised by spasticity, dystonia or both. This can result in significant difficulty with activities of daily living, pain and long term joint deformity. There are a number of treatments available for the management of spasticity and dystonia. This review will examine indications and pr...
متن کاملIntrathecal baclofen treatment in dystonic cerebral palsy: a randomized clinical trial: the IDYS trial
BACKGROUND Dystonic cerebral palsy is primarily caused by damage to the basal ganglia and central cortex. The daily care of these patients can be difficult due to dystonic movements. Intrathecal baclofen treatment is a potential treatment option for dystonia and has become common practice. Despite this widespread adoption, high quality evidence on the effects of intrathecal baclofen treatment o...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- Pediatric rehabilitation
دوره 8 3 شماره
صفحات -
تاریخ انتشار 2005